Overview A Pharmacokinetic Study of TS-142 in Patients With Hepatic Impairment Status: Not yet recruiting Trial end date: 2023-11-30 Target enrollment: Participant gender: Summary This is an open-label pharmacokinetic study of TS-142 in patients with hepatic impairment Phase: Phase 1 Details Lead Sponsor: Taisho Pharmaceutical Co., Ltd.